These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1875284)

  • 1. An initial slope method for model structure: independent estimation of the elimination rate constant of a metabolite.
    Piotrovskii VK
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):311-8. PubMed ID: 1875284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An area function method for calculating the apparent elimination rate constant of a metabolite.
    Cheng HY; Jusko WJ
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):125-30. PubMed ID: 2715930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of rate constants for isolating a metabolite by a model-independent method].
    Piotrovskiĭ VK
    Biofizika; 1991; 36(5):899-903. PubMed ID: 1799604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for calculating the mean absorption time of drugs undergoing reversible and first-pass metabolism.
    Cheng H; Shum L
    Biopharm Drug Dispos; 1993 Jan; 14(1):71-9. PubMed ID: 8427946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analyses.
    Bonate PL
    J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):101-15. PubMed ID: 23288469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconvolution method for assessing the absorption of a drug with reversible metabolic pathways.
    Hwang S; Knowles M
    J Pharm Sci; 1994 May; 83(5):629-31. PubMed ID: 8071809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A versatile computational method for the determination of areas under the curve and moment curve following multidose drug administration.
    Yamashita TS; Lee HL; Reed MD
    Int J Biomed Comput; 1988 Dec; 23(3-4):239-49. PubMed ID: 3225062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Area-based estimation of the initial volume of distribution and elimination rate constant following intravenous bolus injection.
    Khor SP; Johnson SL; Mayersohn M
    J Pharm Sci; 1991 Nov; 80(11):1042-50. PubMed ID: 1815055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of methods for estimating the rate constant of a one-compartment absorption model when absorption and elimination rate constants are equal.
    Hoke JF; Ravis WR
    J Pharm Sci; 1992 Apr; 81(4):401-2. PubMed ID: 1501081
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.
    Weiss M
    Drug Metab Dispos; 1998 Jun; 26(6):562-5. PubMed ID: 9616192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An area function method for estimating the apparent absorption rate constant.
    Cheng H; Staubus AE; Shum L
    Pharm Res; 1988 Jan; 5(1):57-60. PubMed ID: 3244611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of variation in drug elimination on five methods for assessing zero-order drug absorption rates.
    Cheng HY; Jusko WJ
    Pharm Res; 1990 Jan; 7(1):76-9. PubMed ID: 2300540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of absorption kinetics by the phase plane method.
    Dokoumetzidis A; Macheras P
    Pharm Res; 1998 Aug; 15(8):1262-9. PubMed ID: 9706059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of absorption rate constant in a one-compartment model with the profile of the bioavailable dose eliminated as a function of multiples of half-life.
    Macheras P; Symillides M; Reppas C
    J Pharm Sci; 1993 Dec; 82(12):1298-300. PubMed ID: 8308718
    [No Abstract]   [Full Text] [Related]  

  • 20. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.
    Veng-Pedersen P; Gillespie WR
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):305-25. PubMed ID: 3668806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.